Brief: Kezar Life Sciences Announces Clinical Hold Of Zetomipzomib Ind For Treatment Of Lupus Nephritis

Kezar Life Sciences

04/10/2024 22:42

Kezar Life Sciences Inc  KZR.O :
    * KEZAR LIFE SCIENCES ANNOUNCES CLINICAL HOLD OF
ZETOMIPZOMIB IND
FOR TREATMENT OF LUPUS NEPHRITIS
    * KEZAR LIFE SCIENCES INC - FDA PLACES CLINICAL HOLD ON
KEZAR'S
ZETOMIPZOMIB IND FOR LUPUS NEPHRITIS
    * KEZAR LIFE SCIENCES: ACTION FOLLOWS CO'S COMMUNICATION TO
FDA
THAT CO WAS SUSPENDING ENROLLMENT, DOSING IN PHASE 2B PALIZADE
CLINICAL TRIAL

Source text for Eikon:  ID:nBw1jsgqsa 
Further company coverage:  KZR.O